{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:19:05Z","timestamp":1792801145840,"version":"4.5.0"},"reference-count":15,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2025,10,1]]},"DOI":"10.1001\/jamaneurol.2025.2559","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T15:00:32Z","timestamp":1754319632000},"page":"983","source":"Crossref","is-referenced-by-count":2,"title":["Emergence of Anti-CD20 Therapies for Individuals With Multiple Sclerosis Planning Pregnancy"],"prefix":"10.1001","volume":"82","author":[{"given":"Kristen M.","family":"Krysko","sequence":"first","affiliation":[{"name":"BARLO MS Centre, Division of Neurology, Department of Medicine, St Michael\u2019s Hospital, Toronto, Ontario, Canada"},{"name":"Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Li Ka Shing Knowledge Institute, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"ned250007r1","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1056\/NEJM199807303390501","article-title":"Rate of pregnancy-related relapse in multiple sclerosis.","volume":"339","author":"Confavreux","year":"1998","journal-title":"N Engl J Med"},{"issue":"2","key":"ned250007r2","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000959","article-title":"Clinical and radiologic disease activity in pregnancy and postpartum in MS.","volume":"8","author":"Anderson","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"24","key":"ned250007r3","doi-asserted-by":"publisher","first-page":"e2989","DOI":"10.1212\/WNL.0000000000012084","article-title":"Natalizumab, fingolimod and dimethyl fumarate use and pregnancy-related relapse and disability in women with multiple sclerosis.","volume":"96","author":"Yeh","year":"2021","journal-title":"Neurology"},{"issue":"4","key":"ned250007r4","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200110","article-title":"Multiple sclerosis disease activity and disability following cessation of fingolimod for pregnancy.","volume":"10","author":"Hellwig","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"ned250007r5","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.44750","article-title":"Multiple sclerosis disease activity and disability following discontinuation of natalizumab for pregnancy.","volume":"5","author":"Hellwig","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"ned250007r6","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000913","article-title":"Anti-CD20 therapies and pregnancy in neuroimmunologic disorders: a cohort study from Germany.","volume":"8","author":"K\u00fcmpfel","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"11","key":"ned250007r7","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1002\/acn3.51893","article-title":"Anti-CD20 monoclonal antibody therapy in postpartum women with neurological conditions.","volume":"10","author":"Anderson","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"ned250007r8","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200328","article-title":"Disease activity in pregnant and postpartum women with multiple sclerosis receiving ocrelizumab or other disease-modifying therapies.","volume":"11","author":"Yeh","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6","key":"ned250007r9","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000903","article-title":"Disease activity in pregnancy and postpartum in women with MS who suspended rituximab and natalizumab.","volume":"7","author":"Razaz","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"7","key":"ned250007r10","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1001\/jamaneurol.2014.209","article-title":"Natalizumab use during the third trimester of pregnancy.","volume":"71","author":"Haghikia","year":"2014","journal-title":"JAMA Neurol"},{"issue":"4","key":"ned250007r11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S1474-4422(20)30067-3","article-title":"Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study.","volume":"19","author":"He","year":"2020","journal-title":"Lancet Neurol"},{"key":"ned250007r12","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.103389","article-title":"Effect of desire for pregnancy on decisions to escalate treatment in multiple sclerosis care: differences between MS specialists and non-MS specialists.","volume":"57","author":"Saposnik","year":"2022","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"ned250007r13","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S1474-4422(22)00426-4","article-title":"Family planning considerations in people with multiple sclerosis.","volume":"22","author":"Krysko","year":"2023","journal-title":"Lancet Neurol"},{"key":"ned250007r14","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2025.2550","article-title":"Therapeutic management during pregnancy and relapse risk in women with multiple sclerosis.","author":"Gavoille","year":"2025","journal-title":"JAMA Neurol"},{"key":"ned250007r15","author":"Hellwig","year":"2024"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2837166\/jamaneurology_krysko_2025_ed_250007_1758903900.80561.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T15:01:44Z","timestamp":1760367704000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2837166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2025.2559","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,1]]}}}